GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Beginning Cash Position

JW Pharmaceutical (XKRX:001060) Beginning Cash Position : ₩15,909 Mil (As of Mar. 2024)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Beginning Cash Position?

JW Pharmaceutical's Beginning Cash Position for the quarter that ended in Mar. 2024 was ₩15,909 Mil.

JW Pharmaceutical's quarterly Beginning Cash Position increased from Sep. 2023 (₩15,915 Mil) to Dec. 2023 (₩33,121 Mil) but then declined from Dec. 2023 (₩33,121 Mil) to Mar. 2024 (₩15,909 Mil).

JW Pharmaceutical's annual Beginning Cash Position increased from Dec. 2021 (₩10,451 Mil) to Dec. 2022 (₩33,366 Mil) and increased from Dec. 2022 (₩33,366 Mil) to Dec. 2023 (₩33,898 Mil).

JW Pharmaceutical Beginning Cash Position Historical Data

The historical data trend for JW Pharmaceutical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Beginning Cash Position Chart

JW Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30,948.42 41,864.25 10,451.34 33,366.48 33,897.93

JW Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33,897.93 23,568.94 15,914.68 33,120.64 15,908.87

JW Pharmaceutical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

JW Pharmaceutical Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Pharmaceutical (XKRX:001060) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Beginning Cash Position
Comparable Companies
XKRX:003850 XKRX:019170 XKRX:000640 XKRX:003090 XKRX:086450 XKRX:243070 XKRX:170900 XKRX:249420 XKRX:003000 XKRX:003520 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
001067:Korea 001065.PFD:Korea
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
Website
https://www.jw-pharma.co.kr
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical (XKRX:001060) Headlines

No Headlines